Volume 11, Issue 2 (March & April - Special Issue on COVID-19 2020)                   BCN 2020, 11(2): 201-206 | Back to browse issues page

XML Print

1- Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Introduction: To assess the opinion of patients with Multiple Sclerosis (MS) on the outcomes of COVID-19 (coronavirus disease 2019) and its effects on MS symptoms if they catch coronavirus. A cross-sectional study was performed. 
Methods: Considering the study objectives, a questionnaire was designed and prepared as a Google Form for MS patients for one week. 
Results: A total of 148 MS patients with an average age of 35.73 years completed the questionnaire. The most important concern of the participants was “a high prevalence of COVID-19” following by the “MS symptoms worsening”. Many participants (35%) believed that, if they catch COVID-19 they will be cured. However, the treatment will take more time for them in comparison with the general population. About 39.8% of the patients stated that COVID-19 infection does not affect the MS symptom, but others noted that, it can cause relapse (30.8%) or worsen MS symptoms (29.3%).
Conclusion: This study revealed that MS patients are more anxious about the effects of COVID-19 on their underlying disease rather than the infection itself. 
Full-Text [PDF 538 kb]   |   |   Full-Text (HTML)   
Type of Study: Commentary | Subject: Behavioral Neuroscience
Received: 2020/04/25 | Accepted: 2020/06/13 | Published: 2020/06/14

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.